Skip to main content
. 2020 Sep 22;10(9):e042341. doi: 10.1136/bmjopen-2020-042341

Table 6.

Comparison of the serological parameters in patients with different clinical stages of gastric cancer, M (P25, P75)

Clinical stage Cases
(n)
PG I (μg/L) PG II (μg/L) PG I/II ratio Gastrin-17 (pmol/L)
Early 49 93.07 (68.39, 171.64) 13.81 (7.42, 23.92) 6.95 (5.71, 9.73) 5.93 (2.85, 12.75)
Advanced 131 118.23 (69.43, 181.24) 19.43 (12.51, 30.41) 6.10 (4.50, 8.03) 8.19 (4.29, 14.39)
 Ζ 0.88 2.33 2.43 1.75
 P value 0.38 0.02 0.02 0.08

PG, pepsinogen.